AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
Position
Director
Company
Stoke Therapeutics, Inc.
BedfordBiotechnologyHealth CareTherapeuticsDescription
On September 23, 2026, Stoke Therapeutics appointed Alexander (Bo) Cumbo to its Board of Directors as a Class III director. This appointment follows the resignation of Edward M. Kaye, M.D., who notified the Board of his intent to resign effective September 23, 2026
Fundz sees it the moment Stoke Therapeutics, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Stoke Therapeutics, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.